| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
郑荣寿，张思维，孙可欣，等.2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志，2023, 45(3): 212-220.
|
| [3] |
Rossi L, Mazzara C, Pagani O. Diagnosis and treatment of breast cancer in young women[J]. Curr Treat Options Oncol, 2019, 20(12): 86.
|
| [4] |
艾勇彪，袁杰，李文仿，等. 不同分子分型青年乳腺癌的临床特点及预后因素分析[J]. 中国医药导报，2020, 17(8): 117-120.
|
| [5] |
Chang EM, Lim E, Yoon S, et al. Cisplatin induces overactivation of the dormant primordial follicle through PTEN/AKT/FOXO3a pathway which leads to loss of ovarian reserve in mice[J]. PLoS One, 2015, 10(12): e0144245.
|
| [6] |
曹技磊，董懿，王钢乐. 绝经前乳腺癌患者化疗致闭经的发生率及其影响因素分析[J]. 川北医学院学报，2021，36(1)：91-94.
|
| [7] |
Sudour H, Chastagner P, Claude L, et al. Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors[J]. Int J Radiat Oncol Biol Phys. 2010, 76(3)：867-873.
|
| [8] |
Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries[J]. Int J Radiat Oncol Biol Phys. 2005, 62(3)：738-744.
|
| [9] |
Anderson RA, Mitchell RT, Kelsey TW, et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults[J]. Lancet Diabetes Endocrinol, 2015, 3(7): 556-567.
|
| [10] |
王秋毅，朱慧莉，黄薇，等. 女性恶性肿瘤患者的生育力保护策略[J]. 中国计划生育学杂志，2021, 29(1): 207-210.
|
| [11] |
Corney RH, Swinglehurst AJ. Young childless women with breast cancer in the UK: a qualitative study of their fertility-related experiences, options, and the information given by health professionals[J]. Psychooncology, 2014, 23(1): 20-26.
|
| [12] |
Nagy ZP, Shapiro D, Chang CC. Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment[J]. Fertil Steril, 2020, 113(2): 241-247.
|
| [13] |
van Leeuwen FE, Klip H, Mooij TM, et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort[J]. Hum Reprod, 2011, 26(12): 3456-3465.
|
| [14] |
Stewart LM, Holman CD, Hart R, et al. In vitro fertilization and breast cancer: is there cause for concern? [J]. Fertil Steril, 2012, 98(2): 334-340.
|
| [15] |
Marjoribanks J, Farquhar C, Roberts H, et al. Long term hormone therapy for perimenopausal and postmenopausal women[J]. Cochrane Database Syst Rev, 2012, (7): CD004143.
|
| [16] |
Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy[J]. J Clin Endocrinol Metab, 2006, 91(10): 3885-3890.
|
| [17] |
中国妇幼保健协会生育力保存专业委员会. 女性生育力保存临床实践中国专家共识[J]. 中华生殖与避孕杂志，2021, 41(5): 383-391.
|
| [18] |
Goldrat O, Kroman N, Peccatori FA, et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome[J]. Eur J Cancer, 2015, 51(12): 1490-1496.
|
| [19] |
Luke B, Brown MB, Missmer SA, et al. Assisted reproductive technology use and outcomes among women with a history of cancer[J]. Hum Reprod, 2016, 31(1): 183-189.
|
| [20] |
Cobo A, García-Velasco J, Domingo J, et al. Elective and onco-fertility preservation: factors related to IVF outcomes[J]. Hum Reprod, 2018, 33(12): 2222-2231.
|
| [21] |
Marklund A, Eloranta S, Wikander I, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study[J]. Hum Reprod, 2020, 35(4): 929-938.
|
| [22] |
Hoekman EJ, Louwe LA, Rooijers M, et al. Ovarian tissue cryopreservation: low usage rates and high live-birth rate after transplantation[J]. Acta Obstet Gynecol Scand, 2020, 99(2): 213-221.
|
| [23] |
Ladanyi C, Mor A, Christianson MS, et al. Recent advances in the field of ovarian tissue cryopreservation and opportunities for research[J]. J Assist Reprod Genet, 2017, 34(6): 709-722.
|
| [24] |
Rodriguez-Wallberg KA, Oktay K. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer[J]. Oncologist, 2012, 17(11): 1409-1417.
|
| [25] |
Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion[J]. Fertil Steril, 2013, 100(5): 1224-1231.
|
| [26] |
Dueholm Hjorth IM, Kristensen SG, Dueholm M, et al. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue[J]. Fertil Steril, 2020, 114(2): 379-387.
|
| [27] |
Lambertini M, Goldrat O, Ferreira AR, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients[J]. Ann Oncol, 2018, 29(1): 237-243.
|
| [28] |
Lambertini M, Moore HCF, Leonard RCF, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data[J]. J Clin Oncol, 2018, 36(19): 1981-1990.
|
| [29] |
Zhong Y, Lin Y, Cheng X, et al. GnRHa for ovarian protection and the association between AMH and ovarian function during adjuvant chemotherapy for breast cancer[J]. J Cancer, 2019, 10(18): 4278-4285.
|
| [30] |
Zong X, Yu Y, Yang H, et al. Effects of gonadotropin-releasing hormone analogs on ovarian function against chemotherapy-induced gonadotoxic effects in premenopausal women with breast cancer in China: a randomized clinical trial[J]. JAMA Oncol, 2022, 8(2): 252-258.
|
| [31] |
Ribi K, Luo W, Bernhard J, et al. Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: patient-reported outcomes in the suppression of ovarian function trial[J]. J Clin Oncol, 2016, 34(14): 1601-1610.
|
| [32] |
Sukumar JS, Quiroga D, Kassem M, et al. Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer[J]. Breast Cancer Res Treat, 2021, 190(2): 183-188.
|
| [33] |
Senra JC, Roque M, Talim MCT, et al. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2018, 51(1): 77-86.
|
| [34] |
Sinha N, Letourneau JM, Wald K, et al. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer[J]. J Assist Reprod Genet, 2018, 35(10): 1861-1868.
|
| [35] |
Munhoz RR, Pereira AA, Sasse AD, et al. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis[J]. JAMA Oncol, 2016, 2(1): 65-73.
|
| [36] |
Lambertini M, Blondeaux E, Bruzzone M, et al. Pregnancy after breast cancer: a systematic review and meta-analysis[J]. J Clin Oncol, 2021, 39(29): 3293-3305.
|
| [37] |
Kang M, Chun YS, Park HK, et al. Subsequent pregnancy and long-term safety after breast cancer: a retrospective analysis of Korean health insurance data[J]. Ann Surg Treat Res, 2022, 102(2): 73-82.
|
| [38] |
Hartman EK, Eslick GD. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis[J]. Breast Cancer Res Treat, 2016, 160(2): 347-360.
|
| [39] |
Lambertini M, Kroman N, Ameye L, et al. Long-term safety of pregnancy following breast cancer according to estrogen receptor status[J]. J Natl Cancer Inst, 2018, 110(4): 426-429.
|
| [40] |
Condorelli M, Bruzzone M, Ceppi M, et al. Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer[J]. ESMO Open, 2021, 6(6): 100 300.
|
| [41] |
Lambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2020, 31(12): 1664-1678.
|
| [42] |
Hartnett KP, Mertens AC, Kramer MR, et al. Pregnancy after cancer: Does timing of conception affect infant health? [J]. Cancer, 2018, 124(22): 4401-4407.
|
| [43] |
Perachino M, Poggio F, Arecco L, et al. Update on pregnancy following breast cancer diagnosis and treatment[J]. Cancer J, 2022, 28(3): 176-182.
|
| [44] |
Burstein HJ, Curigliano G, Loibl S, et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019[J]. Ann Oncol, 2019, 30(10): 1541-1557.
|
| [45] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版) [J]. 中国癌症杂志，2019, 29(8): 609-679.
|
| [46] |
Wenners A, Grambach J, Koss J, et al. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial[J]. BMC Cancer, 2017, 17(1): 632.
|
| [47] |
Dolmans MM, Donnez J, Cacciottola L. Fertility preservation: the challenge of freezing and transplanting ovarian tissue[J]. Trends Mol Med, 2021, 27(8): 777-791.
|
| [48] |
Chiti MC, Dolmans MM, Donnez J, et al. Fibrin in reproductive tissue engineering: a review on its application as a biomaterial for fertility preservation[J]. Ann Biomed Eng, 2017, 45(7): 1650-1663.
|
| [49] |
Salama M, Woodruff TK. From bench to bedside: current developments and future possibilities of artificial human ovary to restore fertility[J]. Acta Obstet Gynecol Scand, 2019, 98(5): 659-664.
|
| [50] |
Kim YJ, Shin JH, Hur JY, et al. Predictive value of serum progesterone level on β-hCG check day in women with previous repeated miscarriages after in vitro fertilization[J]. PLoS One, 2017, 12(7): e0181229.
|
| [51] |
Chen J, Todorov P, Isachenko E, et al. Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration[J]. Hum Fertil (Camb), 2022, 25(4): 651-661.
|
| [52] |
Chen J, Isachenko E, Wang W, et al. Optimization of follicle isolation for bioengineering of human artificial ovary[J]. Biopreserv Biobank, 2022, 20(6): 529-539.
|
| [53] |
Schmidt VM, Isachenko E, Rappl G, et al. Construction of human artificial ovary from cryopreserved ovarian tissue: appearance of apoptosis and necrosis after enzymatic isolation of follicles[J]. Cryobiology, 2018, 84: 10-14.
|
| [54] |
Oktem O, Urman B. Understanding follicle growth in vivo[J]. Hum Reprod, 2010, 25(12): 2944-2954.
|
| [55] |
Dath C, Dethy A, Van Langendonckt A, et al. Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells[J]. Hum Reprod, 2011, 26(6): 1431-1439.
|
| [56] |
Amorim CA, Shikanov A. The artificial ovary: current status and future perspectives[J]. Future Oncol, 2016, 12(20): 2323-2332.
|
| [57] |
Laronda MM, Rutz AL, Xiao S, et al. A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice[J]. Nat Commun, 2017, 8: 15261.
|
| [58] |
Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation[J]. Fertil Steril, 2013, 99(6): 1503-1513.
|
| [59] |
Kniazeva E, Hardy AN, Boukaidi SA, et al. Primordial follicle transplantation within designer biomaterial grafts produce live births in a mouse infertility model[J]. Sci Rep, 2015, 5: 17709.
|
| [60] |
Cho E, Kim YY, Noh K, et al. A new possibility in fertility preservation: a artificial ovary[J]. J Tissue Eng Regen Med, 2019, 13(8): 1294-1315.
|
| [61] |
Silvestris E, Cafforio P, D’Oronzo S, et al. In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization[J]. Hum Reprod, 2018, 33(3): 464-473.
|
| [62] |
Woods DC, Khrapko K, Tilly JL. Influence of maternal aging on mitochondrial heterogeneity, inheritance, and function in oocytes and preimplantation embryos[J]. Genes (Basel), 2018, 9(5): 265.
|